Home » Newsletters » BioWorld Science

BioWorld Science

June 14, 2017

View Archived Issues

New S1P1-specific PET radioligands for imaging neuroinflammation show promise

Sunovion files IND for second compound from drug discovery collaboration with PsychoGenics

OSE Immunotherapeutics collaborates with Memorial Sloan Kettering on OSE-703

Carma Therapeutics closes initial financing

DSMB recommends continuation of NASH-CX trial of GR-MD-02

FDA awards fast track designation to tanezumab for chronic pain indications

AbbVie and Principia Biopharma establish oral immunoproteasome inhibitor collaboration

[18F]FC-0324, a new PET tracer targeting cannabinoid CB2 receptors

Zafgen details results from first-in-human trial of obesity candidate ZGN-1061

Jiangsu Chia Tai Tianqing Pharmaceutical Group presents ALK inhibitors

Moleculin Biotech starts IND preparation for WP-1220 for CTCL

Leo Pharma patents 3-triazolo-3-deoxy-ingenol derivatives

AbbVie discovers 5-HT2C receptor agonists

Pulmatrix in-licenses RespiVert kinase inhibitors

Ohara Pharmaceutical discloses prodrugs of azacytidine and decitabine

Genentech and Xenon Pharmaceuticals disclose Nav1.7 channel blockers

Grant supports BrainStorm Cell Therapeutics' development of NurOwn

Galapagos compound GLPG-1690 given U.S. orphan designation for idiopathic pulmonary fibrosis

NCI grant supports continued research at Case Western on Barrett's esophagus

[18F]GE-180 evaluated in patients with high grade glioma and multiple sclerosis

AbbVie drug receives FDA orphan status for onchocerciasis and lymphatic filariasis

IT-139 named a U.S. orphan drug for pancreatic cancer

FDA grants breakthrough therapy designation for OMS-721 in IgA nephropathy

Phase III trial of Bronchitol in cystic fibrosis meets primary endpoint

Cellth Systems granted rights to CTC cell-tethering technology

Repurposed cancer drug SU-9516 may have potential for Duchenne muscular dystrophy

FDA issues 510(k) clearance for Techlab's E. Histolytica Quik Chek test

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Gene therapies aim for the big goal of edits in vivo
BioWorld Science
The field of gene therapy is experiencing major advances driven by precise editing technologies, such as base and prime editing, and by the design of increasingly...